Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지
DOI QR코드

DOI QR Code

Rhynchophylline, One of Major Constituents of Uncariae Ramulus et Uncus Enhances Pentobarbital-induced Sleep Behaviors and Rapid Eye Movement Sleep in Rodents

  • Yoo, Jae Hyeon (College of Pharmacy, Chungbuk National University) ;
  • Ha, Tae-Woo (College of Pharmacy, Chungbuk National University) ;
  • Hong, Jin Tae (College of Pharmacy, Chungbuk National University) ;
  • Oh, Ki-Wan (College of Pharmacy, Chungbuk National University)
  • Received : 2016.06.23
  • Accepted : 2016.08.20
  • Published : 2016.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Rhynchophylline (RP) is a major tetracyclic oxindole alkaloid of Uncariae Ramulus et Uncus which has been used to treat hypertension, seizures, pain and anxiety in the oriental countries. A recent report revealed that RP attenuated ischemia-induced neuronal damage and kainite-induced convulsions in animals. This study was performed to investigate whether RP enhances pentobarbital-induced sleep behaviors and modulates sleep architecture in mice. Locomotor activity was significantly inhibited by RP at 0.25 and 0.5 mg/kg, similar to 2 mg/kg diazepam (a benzodiazepine agonist) in mice. RP shortened sleep latency and increased total sleep time in a dose-dependent manner when administrated with pentobarbital (42 mg/kg, i.p.). RP also increased the number of sleeping mice and total sleep time by concomitant administration with the sub-hypnotic dosage of pentobarbital (28 mg/kg, i.p.). On the other hand, RP (0.25 mg/kg, p.o.) itself significantly inhibited sleep-wake cycles, prolonged total sleep time, and rapid eye movement in rats. In addition, RP also increased chloride influx in the primary cultured hypothalamic neuronal cells. In addition, we found that glutamic acid decarboxylase ($GAD_{65/67}$) was activated by RP. In conclusion, RP augments pentobarbital-induced sleeping behaviors, and can be a candidate for treating insomnia.

Keywords

References

  1. Kim, C. S.; Han, J. Y.; Kim, S. h.; Hong, J. T.; Oh, K. W.; Biomolecules & Therapeutics, 2011, 19, 274-281. https://doi.org/10.4062/biomolther.2011.19.3.274
  2. Macdonald, R. L.; Olsen, R. W. Annu.Rrv Neurosci. 1994, 17, 569- 602. https://doi.org/10.1146/annurev.ne.17.030194.003033
  3. Sieghart, W. Pharmaco. Rev. 1995, 47, 181-234.
  4. Seifi, M.; Brown, J. F.; Mills, J.; Bhandari, P.; Belelli, D.; Lambert, J. J.; Rudolph, U.; Swinny, J. D. J. Neurosci. 2014, 34, 10361-10378. https://doi.org/10.1523/JNEUROSCI.0441-14.2014
  5. Wang, W.; Xu, T. L. Neurosci. Lett. 2006, 406, 11-16. https://doi.org/10.1016/j.neulet.2006.06.064
  6. Abourashed, E. A.; Koetter, U,; Brattstrom, A. Phytomedicine. 2004, 11, 633-638. https://doi.org/10.1016/j.phymed.2004.03.005
  7. Zhang, W. B.; Chen, C. X.; Sim, S. M.; Kwan, C. Y. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369, 232-238. https://doi.org/10.1007/s00210-003-0854-9
  8. Kang, T. H.; Murakami, Y.; Takayama, H.; Kitajima, M.; Aimi, N.; Watanabe, H.; Matsumoto, K. Life Sci. 2004, 76, 331-343. https://doi.org/10.1016/j.lfs.2004.08.012
  9. Yuan, D.; Ma, B.; Yang, J. Y.; Xie, Y. Y.; Wang, L.; Zhang, L.; Kano, Y.; Wu, C. F.; Int. Immunopharmacol. 2009, 9, 1549-1554. https://doi.org/10.1016/j.intimp.2009.09.010
  10. Kang, T. H.; Murakami, Y.; Matsumoto, K.; Takayama, H.; Kitajima, M.; Aimi, N.; Watanabe, H.; Eur. J. Pharmacol. 2002, 455, 27-34. https://doi.org/10.1016/S0014-2999(02)02581-5
  11. Morton, G. J.; Kaiyala, K. J.; Fisher, J. D.; Ogimoto, K.; Schwartz, M. W.; Wisse, B. E. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E392-E401. https://doi.org/10.1152/ajpendo.00546.2010
  12. Zhenzhen, H.; Kim, C. S.; Oh, E. H.; Lee, M. K.; Eun, J. S.; Hong, J. T.; Oh, K. W. Nat. Prod. Sci. 2012, 18, 67-75.
  13. Wolfman, C.; Viola, H.; Marder, M.; Wasowski, C.; Ardenghi, P.; Izquierdo, I.; Paladini, A. C.; Medina, J. H. Eur. J. Pharmacol. 1996, 318, 23-30. https://doi.org/10.1016/S0014-2999(96)00784-4
  14. Paxinos, G.; Watson, C.; Pennisi, M.; Topple, A. J. Neurosci. Methods 1985, 13, 139-143. https://doi.org/10.1016/0165-0270(85)90026-3
  15. Sanford, L. D.; Yang, L.; Liu, X.; Tang, X. Brain Res. 2006, 1084, 80-88. https://doi.org/10.1016/j.brainres.2006.02.020
  16. Tokunaga, S.; Takeda, Y.; Niimoto, T.; Nishida, N.; Kubo, T.; Ohno, T.; Matsuura, Y.; Kawahara, Y.; Shinomiya, K.; Kamei, C. Biol. Pharm. Bull. 2007, 30, 363-366. https://doi.org/10.1248/bpb.30.363
  17. Ma, Y.; Eun, J. S.; Lee, K. S.; Lee, E. S.; Kim, C. S.; Hwang, B. Y.; Oh, K. W. Nat. Prod. Sci. 2009, 15, 213-221.
  18. Ma, Y.; Han, H.; Eun, J. S.; Kim, H. C.; Hong, J. T.; Oh, K. W. Biol. Pharm. Bull. 2007, 30, 1748-1753. https://doi.org/10.1248/bpb.30.1748
  19. West, M. R.; Molloy, C. R. Anal. Biochem. 1996, 241, 51-58. https://doi.org/10.1006/abio.1996.0377
  20. Wagner, C.; Vargas, A. P.; Roos, D. H.; Morel, A. F.; Farina, M.; Nogueira, C. W.; Aschner, M.; Rocha, J. B. Arch. Toxicol. 2010, 84, 89-97. https://doi.org/10.1007/s00204-009-0482-3
  21. Han, S.; Niu, W.; Li, H.; Hu, L.; Yuan, Y.; Xu, G. Talanta 2010, 81, 44-47. https://doi.org/10.1016/j.talanta.2009.11.037
  22. Shi, J. S.; Yu, J. X.; Chen, X. P.; Xu, R. X. Acta Pharmacol. Sin. 2003, 24, 97-101.
  23. Zhou, J.; Zhou, S. J. Ethnopharmacol. 2010, 132, 15-27. https://doi.org/10.1016/j.jep.2010.08.041
  24. Trachsel, L.; Tobler, I.; Achermann, P.; Borbely, A. A. Physiol. Behav. 1991, 49, 575-580. https://doi.org/10.1016/0031-9384(91)90283-T
  25. Gottesmann, C. Neurosci. Biobehav. Rev. 1996, 20, 367-387. https://doi.org/10.1016/0149-7634(95)00055-0
  26. Datta, S. Hobson, J. A. Behav. Neurosci. 2000, 114, 1239-1244. https://doi.org/10.1037/0735-7044.114.6.1239
  27. Siegel, J. M. Nature 2005, 437, 1264-1271. https://doi.org/10.1038/nature04285
  28. Erlander, M. G. Tobin, A. J. Neurochem. Res. 1991, 16, 215-226. https://doi.org/10.1007/BF00966084
  29. Esclapez, M.; Tillakaratne, N. J.; Kaufman, D. L.; Tobin, A. J.; Houser, C. R. J. Neurosci. 1994, 14, 1834-1855. https://doi.org/10.1523/JNEUROSCI.14-03-01834.1994
  30. Rudolph, U.; Mohler, H. Curr. Opin. Pharmacol. 2006, 6, 18-23. https://doi.org/10.1016/j.coph.2005.10.003

Cited by

  1. Cellular Effects of Rhynchophylline and Relevance to Sleep Regulation vol.3, pp.2, 2021, https://doi.org/10.3390/clockssleep3020020